Reviewed November 16, 2026

Benchling

Private
benchling.com

Life-sciences research platform

Company overview

Revenue
~$210M ARR
May 2024 · Estimate
Reference valuation
$6.1B
Historical Series F · Nov 2021
Primary customer
Biotech and pharmaceutical scientists[1]
Commercial model
Software subscriptions[1]

Revenue is an independently estimated measure. The valuation is a dated transaction reference, not a current appraisal.[1]

Customers
1,200[1]
May 2024 · historical count

Revenue history

Revenue

ARR · USD

+14%

May 2024 vs. Dec 2023 · calculated change; not annualized

$0$125M$250MDec 2023May 2024
Revenue observations and evidence
PeriodUSDEvidence
$185MEstimate
$210MEstimate

Sacra · company research and financial history ↗

ARR observations are point-in-time measures, not completed annual revenue.

Points show dated observations at equal spacing; intervening performance is not measured.

Products, customers & revenue model

ProductCustomerCommercial model
Research platform[1]Biotech and pharmaceutical scientists

Software subscriptions

Implementation[1]Life-sciences organizations

Professional services

Business economics

What drives the business
Enterprise deployments require services. Customer expansion and implementation economics both matter.[1]

Leadership & functional coverage

Selected leaders supported by the linked sources; dated appointments retain their source context. This is not a complete org chart. Advisory roles are labeled.

LeaderRoleFunction / context
Sajith WickramasekaraCofounder & CEOCompany leadership[2]
Ashu SinghalCofounderCompany leadership[2]
Ron GillFinance leadershipFunction listed in company leadership directory[2]
Meg MakalouPeople leadershipFunction listed in company leadership directory[2]
Julie HwangLegal leadershipFunction listed in company leadership directory[2]
Brent MosherCustomer Experience leadershipFunction listed in company leadership directory[2]
Yvonne ChenMarketing leadershipFunction listed in company leadership directory[2]
Vineet GopalTechnology leadershipFunction listed in company leadership directory[2]

Dated financial disclosures

DateEvent
May 2024~$210M ARR[1]

Estimate. Revenue observation; separate from the financing date.

Nov 2021$6.1B reference valuation[1]

Historical Series F

Open research questions

  • ↗How much recurring revenue comes from large pharma versus venture-funded biotech?

Sources & definitions

Financial history preserves the source’s measurement basis. ARR, annualized revenue, completed-year sales and transaction volume are distinct. Product economics are Plank analysis of the cited business model; open questions are not asserted findings.

  1. 1Sacra · company research and financial history
  2. 2Company · leadership directory or appointment